Coronary microvascular dysfunction in patients with acute coronary syndrome and non-obstructive coronary artery

Antonio De Vita1, Angelo Giuseppe Marino1, Nello Cambise1

  • 1Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma Department of Cardiovascular Disease.

PubMed

Insights

Patients with myocardial infarction and non-obstructive coronary arteries (MINOCA) have low long-term cardiovascular mortality. Functional capacity, assessed by exercise stress test, independently predicts overall mortality in MINOCA patients.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Diagnostic Imaging

Background:

  • Myocardial infarction with non-obstructive coronary arteries (MINOCA) is increasingly recognized.
  • Long-term outcomes and prognostic predictors in MINOCA patients remain incompletely understood.
  • Previous studies suggest potential adverse outcomes, necessitating long-term follow-up investigations.

Purpose of the Study:

  • To evaluate the long-term prognosis of MINOCA patients.
  • To assess the predictive value of non-invasive coronary functional tests for long-term outcomes.
  • To identify predictors of major adverse cardiovascular events (MACE) and all-cause mortality in MINOCA.

Main Methods:

  • Transthoracic Doppler echocardiography was used to assess coronary blood flow velocity (CBFV) response to ergonovine, adenosine, and cold pressor test (CPT).
  • Exercise stress test (EST) was performed in 30 MINOCA patients and 10 controls.
  • Clinical endpoints, including MACE and all-cause mortality, were assessed at a median follow-up of 10.3 years.

Main Results:

  • MACE occurred in 33.3% of MINOCA patients versus 9.1% in controls (p=0.17).
  • All-cause mortality occurred in 20% of MINOCA patients, primarily from non-cardiovascular causes (p=0.37).
  • EST duration was the only independent predictor of mortality (p=0.041) in MINOCA patients; coronary functional tests did not predict mortality or MACE.

Conclusions:

  • MINOCA patients exhibit a substantial overall mortality but low cardiovascular-specific mortality at long-term follow-up.
  • Functional capacity, as assessed by EST, is the sole independent predictor of global mortality.
  • Non-invasive coronary functional tests, including CBFV response to CPT and adenosine, were not predictive of long-term mortality or MACE in this cohort.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
311
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
329
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
348
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
744